Life Sciences
Data from University of Northumbria provide new insights into life sciences
Published in Mental Health Law Weekly, September 6th, 2008
New investigation results, 'Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications,' are detailed in a study published in Journal of Psychopharmacology. "Venlafaxine, a dual serotonin and noradrenaline re-uptake inhibitor, has been found to be effective at doses below 375 mg daily, but for patients with major depression higher doses can be required. In this retrospective naturalistic study, we investigated the effectiveness and resource implications of prescribing higher than standard doses of venlafaxine (tablet preparation)," scientists writing in the Journal of Psychopharmacology report.
"Ninety-six outpatients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
More Articles from Mental Health Law Weekly
- Addiction Medicine
Forterus, Inc. Completes Its Acquisition of a Better Tomorrow Treatment Center Inc. for $12.85 Million - Association of Flight Attendants-CWA, AFL-CIO
US Airways Executives Receive Millions in Stock While Passengers Continue to be Nickel and Dimed - CyberPatrol LLC
CyberPatrol Urges Implementation of California Cyberbullying Law - Mental Health
Studies conducted at University of California, Institute for Health Policy Studies on mental health in adolescents recently published - Mental Health
Studies from University of California add new findings in the area of mental health - Nationwide
Nationwide Insurance Survey Finds Parents Fed up with "Party Schools" and Politicians Who Support Lowering Drinking Age - More from this issue of Mental Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
